Cargando…
Hypertrophic Cardiomyopathy: How do Mutations Lead to Disease?
Hypertrophic cardiomyopathy (HCM) is the most common monogenic genetic cardiac disease, with an estimated prevalence of 1:500 in the general population. Clinically, HCM is characterized by hypertrophy of the left ventricle (LV) walls, especially the septum, usually asymmetric, in the absence of any...
Autores principales: | Marsiglia, Júlia Daher Carneiro, Pereira, Alexandre Costa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Cardiologia
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987320/ https://www.ncbi.nlm.nih.gov/pubmed/24714796 http://dx.doi.org/10.5935/abc.20140022 |
Ejemplares similares
-
Clinical predictors of a positive genetic test in hypertrophic cardiomyopathy in the Brazilian population
por: Marsiglia, Julia Daher Carneiro, et al.
Publicado: (2014) -
Haploinsufficiency of syncoilin leads to hypertrophic cardiomyopathy
por: Fan, Liang-Liang, et al.
Publicado: (2022) -
Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020) -
Neuromuscular diseases with hypertrophic cardiomyopathy
por: Cesar, Sergi
Publicado: (2018) -
An Update on MYBPC3 Gene Mutation in Hypertrophic Cardiomyopathy
por: Tudurachi, Bogdan-Sorin, et al.
Publicado: (2023)